Abcam

RNA polymerase II CTD repeat YSPTSPS (phospho S5) antibody - ChIP Grade

#ab5131 · western blot

60
Evidence Score · Well-Established
Used by 53 independent labs across 204 papers. How we score this →
200
Citing papers
13.3k
Combined citations
Supplier page Find this product

Research areas

Genomics and Chromatin Dynamics18RNA Research and Splicing14RNA modifications and cancer11Epigenetics and DNA Methylation8Ubiquitin and proteasome pathways5CRISPR and Genetic Engineering5Cancer-related gene regulation5DNA Repair Mechanisms4

Papers citing this product

1
Dynamic Regulation of Nucleosome Positioning in the Human Genome
Cell·2008·1.4k cit.·DOI
2
A Large Fraction of Extragenic RNA Pol II Transcription Sites Overlap Enhancers
PLoS Biology·2010·939 cit.·DOI
3
Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells
Nature Genetics·2009·727 cit.·DOI
4
Multiple exposures to drought 'train' transcriptional responses in Arabidopsis
Nature Communications·2012·641 cit.·DOI
5
ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity
Nucleic Acids Research·2011·318 cit.·DOI
6
H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase
Nature Communications·2015·271 cit.·DOI
7
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
Journal of Clinical Investigation·2013·255 cit.·DOI
8
PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition
Cancer Cell·2016·228 cit.·DOI
9
Vitamin D Induces Interleukin-1β Expression: Paracrine Macrophage Epithelial Signaling Controls M. tuberculosis Infection
PLoS Pathogens·2013·216 cit.·DOI
10
BRD4 is a novel therapeutic target for liver fibrosis
Proceedings of the National Academy of Sciences·2015·212 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.